These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Medical management of endometriosis: a systematic review. Schroder AK; Diedrich K; Ludwig M IDrugs; 2004 May; 7(5):451-63. PubMed ID: 15154107 [TBL] [Abstract][Full Text] [Related]
24. Immunomodulators and aromatase inhibitors: are they the next generation of treatment for endometriosis? D'Hooghe TM Curr Opin Obstet Gynecol; 2003 Jun; 15(3):243-9. PubMed ID: 12858113 [TBL] [Abstract][Full Text] [Related]
25. Novel targets for the treatment of endometriosis. Nothnick WB Expert Opin Ther Targets; 2004 Oct; 8(5):459-71. PubMed ID: 15469395 [TBL] [Abstract][Full Text] [Related]
26. The role of pharmacotherapy in the treatment of endometriosis across the lifespan. Schwartz K; Llarena NC; Rehmer JM; Richards EG; Falcone T Expert Opin Pharmacother; 2020 Jun; 21(8):893-903. PubMed ID: 32164462 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacotherapy for pelvic endometriosis in women]. Starczewski A; Brodowska A; Brodowski J Pol Merkur Lekarski; 2009 Mar; 26(153):231-3. PubMed ID: 19388539 [TBL] [Abstract][Full Text] [Related]
28. Advances in the management of endometriosis: an update for clinicians. Crosignani P; Olive D; Bergqvist A; Luciano A Hum Reprod Update; 2006; 12(2):179-89. PubMed ID: 16280355 [TBL] [Abstract][Full Text] [Related]
29. Endometriosis management: workflow on genomics and proteomics and future biomolecular pharmacotherapy. Tinelli A; Martignago R; Vergara D; Leo G; Malvasi A; Tinelli R Curr Med Chem; 2008; 15(21):2099-107. PubMed ID: 18781937 [TBL] [Abstract][Full Text] [Related]
30. Advances in the medical management of endometriosis. Panay N BJOG; 2008 Jun; 115(7):814-7. PubMed ID: 18485157 [No Abstract] [Full Text] [Related]
32. New drugs in development for the treatment of endometriosis. Fedele L; Somigliana E; Frontino G; Benaglia L; Vigano P Expert Opin Investig Drugs; 2008 Aug; 17(8):1187-202. PubMed ID: 18616415 [TBL] [Abstract][Full Text] [Related]
33. Recent knowledge and new pharmaceutical products in potential alleviation of endometriosis. Vassiliadis S; Athanassakis I Recent Pat Inflamm Allergy Drug Discov; 2008 Jun; 2(2):128-38. PubMed ID: 19076002 [TBL] [Abstract][Full Text] [Related]
34. Medical Management of Endometriosis in Patients with Chronic Pelvic Pain. Bedaiwy MA; Allaire C; Yong P; Alfaraj S Semin Reprod Med; 2017 Jan; 35(1):38-53. PubMed ID: 28002850 [TBL] [Abstract][Full Text] [Related]
35. A review of phase II and III drugs for the treatment and management of endometriosis. Perrone U; Evangelisti G; Laganà AS; Bogliolo S; Ceccaroni M; Izzotti A; Gustavino C; Ferrero S; Barra F Expert Opin Emerg Drugs; 2023 Dec; 28(4):333-351. PubMed ID: 38099328 [TBL] [Abstract][Full Text] [Related]
36. Medical treatment of endometriosis. Garcia-Velasco JA; Quea G Minerva Ginecol; 2005 Jun; 57(3):249-55. PubMed ID: 16166934 [TBL] [Abstract][Full Text] [Related]
37. Endometriosis: alternative methods of medical treatment. Muñoz-Hernando L; Muñoz-Gonzalez JL; Marqueta-Marques L; Alvarez-Conejo C; Tejerizo-García Á; Lopez-Gonzalez G; Villegas-Muñoz E; Martin-Jimenez A; Jiménez-López JS Int J Womens Health; 2015; 7():595-603. PubMed ID: 26089705 [TBL] [Abstract][Full Text] [Related]
39. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain. Ezzati M; Carr BR Womens Health (Lond); 2015 Jan; 11(1):19-28. PubMed ID: 25581052 [TBL] [Abstract][Full Text] [Related]
40. The latest advances in the pharmacological management of endometriosis. Hartner G; Husslein H; Kuessel L; Gstoettner M; Tiringer D; Wenzl R; Perricos A Expert Opin Pharmacother; 2023 Jan; 24(1):121-133. PubMed ID: 35232316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]